YMR209C Antibody

What is YMR209C protein and what is its significance in yeast research?

YMR209C is a protein encoded by the YMR209C gene in Saccharomyces cerevisiae (Baker's yeast), specifically identified in strain ATCC 204508/S288c. As a model eukaryotic organism, S. cerevisiae provides valuable insights into fundamental cellular processes that often have parallels in human biology. The YMR209C protein is studied to understand specific yeast cellular functions, potentially contributing to broader knowledge of eukaryotic systems. Antibodies against this protein enable detection and characterization in various experimental contexts, supporting research into yeast biology and potentially comparative studies with other organisms.

What experimental applications is YMR209C Antibody validated for?

YMR209C Antibody has been specifically validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . These techniques allow researchers to detect, quantify, and characterize YMR209C protein in various sample preparations. The antibody's polyclonal nature (raised in rabbit) provides recognition of multiple epitopes, potentially increasing detection sensitivity while necessitating appropriate experimental controls to ensure specificity.

What are the optimal storage and handling conditions for YMR209C Antibody?

For maximum stability and efficacy, YMR209C Antibody should be stored at -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be strictly avoided as they can compromise antibody integrity and binding capacity. The antibody is supplied in a protective buffer containing 0.03% Proclin 300 (preservative), 50% Glycerol, and 0.01M PBS at pH 7.4 , which helps maintain stability during storage. For experimental use, thaw the antibody on ice or at 4°C and gently mix before use, avoiding vigorous vortexing that could denature the antibody proteins.

How should researchers validate YMR209C Antibody specificity in their model systems?

Rigorous validation is essential before employing YMR209C Antibody in critical experiments. Researchers should:

• Perform comparative Western blot analysis using wild-type S. cerevisiae lysate versus a YMR209C knockout strain

• Include blocking peptide controls to confirm binding specificity

• Verify that the detected protein's molecular weight matches the expected size for YMR209C

• Consider conducting immunoprecipitation followed by mass spectrometry to confirm target identity

• Compare results with alternative detection methods targeting the same protein

These validation steps ensure experimental rigor and reproducibility when working with this antibody.

How can YMR209C Antibody be integrated with yeast surface display platforms?

Yeast surface display represents a powerful platform for antibody engineering and protein interaction studies. While not specifically mentioned for YMR209C in the literature, researchers could potentially employ this approach by:

• Displaying YMR209C protein on the yeast cell surface using established display scaffolds

• Using the YMR209C Antibody to detect the displayed protein and evaluate accessibility of epitopes

• Employing fluorescent-activated cell sorting (FACS) to isolate and enrich yeast cells displaying properly folded YMR209C

• Combining with deep sequencing to track mutational effects on YMR209C structure and function

Recent advances in yeast display technologies have enabled "multiplex navigation of antibody structure" (MINAS) approaches that could potentially be adapted for studying YMR209C interactions . This methodology combines CRISPR/Cas9-based trackable editing with fluorescent-activated cell sorting of yeast display libraries, allowing researchers to systematically map the contribution of specific protein regions to desired properties .

What considerations are important when incorporating YMR209C Antibody in CRISPR/Cas9-based yeast studies?

When utilizing YMR209C Antibody in CRISPR/Cas9 experiments, researchers should consider several factors that influence editing efficiency and experimental outcomes:

The antibody can serve as a valuable tool for detecting changes in YMR209C expression or modification following CRISPR/Cas9 editing, but experimental design should account for these factors that influence the underlying genetic modifications .

How does the polyclonal nature of YMR209C Antibody affect experimental design and interpretation?

YMR209C Antibody is a polyclonal antibody, meaning it contains a heterogeneous mixture of antibodies that recognize different epitopes on the target protein . This characteristic has important experimental implications:

• Advantages: Enhanced sensitivity through recognition of multiple epitopes; greater tolerance to minor protein denaturation or modifications; more robust detection across different experimental conditions

• Considerations: Potential batch-to-batch variability requiring validation between lots; possibility of cross-reactivity with structurally similar proteins; variable affinity for different epitopes affecting quantification

• Mitigation strategies: Include appropriate controls in each experiment; validate new antibody lots against previously characterized samples; consider epitope mapping to understand the range of recognized regions

Researchers should carefully account for these factors when designing quantitative experiments or when comparing results across different studies.

What controls should be included when using YMR209C Antibody in Western blot or ELISA?

Proper experimental controls are critical for generating reliable and interpretable data with YMR209C Antibody:

For Western Blot:

• Positive control: Wild-type S. cerevisiae lysate expressing YMR209C

• Negative control: YMR209C knockout strain lysate or species lacking homologous proteins

• Loading control: Detection of a constitutively expressed yeast protein (e.g., actin)

• Primary antibody control: Substitution with non-specific rabbit IgG

• Secondary antibody control: Omission of primary antibody

For ELISA:

• Standard curve: Serial dilutions of recombinant YMR209C protein

• Background control: Wells without antigen but with both primary and secondary antibodies

• Specificity control: Competitive binding with excess unlabeled YMR209C protein

• Cross-reactivity control: Testing potentially similar proteins from yeast or other species

• Technical replicates: Minimum of three replicates per sample

These controls help distinguish specific signal from background and provide appropriate context for data interpretation.

How can researchers optimize YMR209C Antibody for use in multiplex antibody engineering approaches?

Multiplex antibody engineering, such as the MINAS approach described in the literature, offers powerful opportunities for enhancing antibody properties . For YMR209C Antibody, researchers could:

• Apply CRISPR/Cas9-based trackable editing to introduce specific mutations in complementarity-determining regions (CDRs) and framework regions

• Generate libraries of YMR209C Antibody variants with trackable barcodes for high-throughput screening

• Utilize yeast surface display combined with fluorescence-activated cell sorting to select variants with improved properties

• Apply deep sequencing to map the contribution of each mutation to desired antibody characteristics

Recent research demonstrates that such approaches can identify specific mutations conferring up to 100-fold higher binding affinities compared to wild-type antibodies . For example, researchers have identified mutations like Q27L and S48M that showed 1.4-fold and 2-fold higher binding affinity, respectively, under acidic conditions .

What is the recommended protocol for using YMR209C Antibody in Western blot analysis?

The following optimized protocol is recommended for Western blot analysis using YMR209C Antibody:

• Sample preparation:

  • Lyse S. cerevisiae cells using glass bead disruption in a buffer containing protease inhibitors

  • Clarify lysate by centrifugation (14,000 × g, 10 minutes, 4°C)

  • Quantify protein concentration using Bradford or BCA assay

• Electrophoresis and transfer:

  • Separate 20-40 μg total protein on 10-12% SDS-PAGE

  • Transfer to PVDF membrane (100V for 60 minutes in Towbin buffer)

• Immunoblotting:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with YMR209C Antibody (1:1000 dilution) in 5% BSA/TBST overnight at 4°C

  • Wash 3 × 10 minutes with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

  • Wash 3 × 10 minutes with TBST

  • Develop using enhanced chemiluminescence substrate

• Controls and validation:

  • Include wild-type and YMR209C-deficient samples

  • Probe parallel membrane with housekeeping protein antibody

  • Consider including recombinant YMR209C as positive control

This protocol should be optimized for specific experimental conditions, as antibody performance may vary depending on sample preparation methods and detection systems.

How can researchers troubleshoot common issues when using YMR209C Antibody?

When encountering problems with YMR209C Antibody, consider the following systematic troubleshooting approaches:

Methodical troubleshooting following this framework should resolve most issues encountered when working with YMR209C Antibody in research applications.

What considerations are important for designing ELISA experiments with YMR209C Antibody?

ELISA experiments using YMR209C Antibody require careful optimization of multiple parameters:

• Coating conditions:

  • Optimal antigen concentration: 1-10 μg/ml in carbonate buffer (pH 9.6)

  • Coating temperature: 4°C overnight or 37°C for 2 hours

  • Wash buffer: PBS with 0.05% Tween-20

• Blocking optimization:

  • Test multiple blocking agents (BSA, non-fat milk, commercial blockers)

  • Determine optimal concentration (typically 1-5%)

  • Blocking time: 1-2 hours at room temperature

• Antibody parameters:

  • YMR209C Antibody dilution series: 1:500 to 1:5000

  • Incubation temperature: Room temperature (1-2 hours) or 4°C (overnight)

  • Diluent: Consider adding 0.5% BSA to reduce background

• Detection system:

  • HRP-conjugated secondary antibody (anti-rabbit)

  • Substrate selection based on required sensitivity (TMB, ABTS, etc.)

  • Extended development time for weak signals (5-30 minutes)

• Data analysis:

  • Generate standard curve using purified recombinant YMR209C

  • Determine linear range for quantification

  • Use appropriate curve-fitting models for quantitative analysis

These optimization steps ensure robust and reproducible ELISA results when working with YMR209C Antibody.

How can researchers apply YMR209C Antibody in combination with CRISPR/Cas9-based protein engineering?

Integration of YMR209C Antibody with CRISPR/Cas9 approaches enables sophisticated protein engineering applications:

• Target validation:

  • Use the antibody to confirm expression changes after CRISPR/Cas9 editing of YMR209C gene

  • Quantify protein abundance in wild-type versus edited strains

  • Characterize modified protein variants through immunodetection

• MINAS approach integration:

  • Apply multiplex navigation of antibody structure techniques to systematically map protein regions

  • Use CRISPR/Cas9 to introduce specific mutations in the YMR209C gene

  • Employ the antibody to detect resulting protein changes

• Editing optimization:

  • Consider key factors affecting CRISPR/Cas9 editing efficiency:

    • Shorter distances between PAM and target site (13 bp optimal)

    • Longer homology arms (68 bp showed better efficiency)

    • Target site selection influences success rates significantly

• High-throughput screening:

  • Develop yeast surface display libraries with CRISPR/Cas9-modified YMR209C

  • Apply fluorescence-activated cell sorting with labeled YMR209C Antibody

  • Sequence enriched populations to identify beneficial mutations

Recent advances in CRISPR/Cas9-based editing combined with next-generation sequencing enable thorough investigations of target proteins at single-nucleotide resolution , creating new opportunities for researchers using YMR209C Antibody in sophisticated experimental designs.